About
Enzyme Analogue Inflammation Treatment
Areas of Focus
Categories
Small Molecule PharmaceuticalBoston & New England
Team (9)
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
1
As Collaborator
6
Total Enrollment
3,155
By Phase
NA: 5PHASE1: 1PHASE2/PHASE3: 1
By Status
COMPLETED: 5TERMINATED: 1UNKNOWN: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT05737472Collaborator
High-protein Quantity and Quality RUTF in Improving Linear Growth Among Children With Severe Wasting
NACompleted
128 participants
Started: Nov 14, 2022 · Completed: Aug 23, 2023
NCT04941183Lead Sponsor
Phase 1 Study to Assess Safety, Tolerability, PD, PK, Immunogenicity of IV NTR-441 Solution in Healthy Volunteers and COVID-19 Patients
PHASE1Terminated
52 participants
Started: Apr 14, 2021 · Completed: Jun 6, 2023
NCT03196622Collaborator
Validation of a Screening Test for Sarcopenia in Older People
NAUnknown
1,300 participants
Started: Jul 11, 2017 · Completed: Jun 30, 2019
NCT02716935Collaborator
Prebiotics and Microbiota Composition and Functionality in Rural Burkinabe Infants
NACompleted
153 participants
Started: Mar 31, 2016 · Completed: Nov 30, 2019
NCT01889329Collaborator
Development and Field Testing of Ready-to-use-therapeutic Foods Made of Local Ingredients in Bangladesh for SAM Children
PHASE2/PHASE3Completed
490 participants
Started: Apr 30, 2013 · Completed: Dec 31, 2015
Locations (1)
Headquarters
Cambridge, MA, United States
Map
Loading map...